Latest filing published 03 Aug 2026 for Celsius Holdings, Inc., €6.0M.
First 200 filings with a declared amount
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William H. Milmoe has sold EUR 260.7 million of shares in 51 sales, nearly all at Celsius Holdings, Inc., where the listed title is 10% Owner. The median is EUR 3,287,839. The largest are from August 2, 2022 (EUR 20,012,529), April 30, 2024 (EUR 11,987,309) and April 29, 2024 (EUR 11,932,328). The record also holds 5 purchases worth EUR 4.8 million, or 9% of market trades: EUR 1,808,598 and EUR 1,627,740 on September 12, 2019, then EUR 933,829 on January 31, 2017.
Of 204 filings published from January 18, 2017 to April 17, 2026, 196 concern Celsius Holdings, Inc. and 8 Integrated Biopharma Inc, where Milmoe is a Director. There are also 121 other filings, 21 grants and 6 option exercises.
Activity picks up sharply: 3 filings in 2017, 14 in 2021, 21 in 2023, 37 in 2024, then 87 in 2025. The last twelve months hold 58 filings, with no sale and no purchase.
At Celsius Holdings, Inc., Jarrod Langhans has 39 trades within 30 days of Milmoe's, Dean DeSantis 35, Deborah DeSantis 35 and John Fieldly 33, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 204 declarations